Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. CANADIAN NATIONAL STOCK EXCHANGE
  5. Pharmadrug Inc.
  6. News
  7. Summary
    PHRX   CA71716W1059

PHARMADRUG INC.

(PHRX)
Delayed Quote. Delayed CANADIAN NATIONAL STOCK EXCHANGE - 09/20 03:47:04 pm
0.04 CAD   -11.11%
08/30David Kideckel Joins the Board of Pharmadrug Inc
CI
08/30Biotech Veteran David Kideckel Joins the Board of PharmaDrug
NE
08/27Pharmadrug Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

PharmaDrug : to Change Ticker Symbol

07/23/2021 | 09:18am EDT


ę MT Newswires 2021
All news about PHARMADRUG INC.
08/30David Kideckel Joins the Board of Pharmadrug Inc
CI
08/30Biotech Veteran David Kideckel Joins the Board of PharmaDrug
NE
08/27Pharmadrug Inc. Reports Earnings Results for the Second Quarter Ended June 30..
CI
08/25Pharmadrug Announces Clinical Research Collaboration with the Johns Hopkins U..
CI
08/25PharmaDrug Announces Clinical Research Collaboration with The Johns Hopkins U..
NE
08/09PHARMADRUG : Announces Appointment of Audito
AQ
08/06PharmaDrug Announces Appointment of Auditor
NE
08/05Pharmadrug Inc. Enters into A Sponsored Research Agreement with the Terasaki ..
CI
08/05PharmaDrug Forms Research Collaboration with Terasaki Institute for Novel Ocu..
NE
08/03Pharmadrug Inc. will Change its Ticker to PHRX from BUZZ
CI
More news
Financials
Sales 2020 0,68 M 0,53 M 0,53 M
Net income 2020 -5,15 M -4,02 M -4,02 M
Net cash 2020 3,28 M 2,56 M 2,56 M
P/E ratio 2020 -2,21x
Yield 2020 -
Capitalization 15,3 M 12,0 M 12,0 M
EV / Sales 2019 7,68x
EV / Sales 2020 18,3x
Nbr of Employees -
Free-Float 95,5%
Chart PHARMADRUG INC.
Duration : Period :
Pharmadrug Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Daniel Cohen Chairman & Chief Executive Officer
Keith Li Chief Financial Officer & Secretary
Paul Van Slyke Chief Scientific Officer
Robert Schwartz Independent Director
Paul Gerard Joseph McClory Independent Director
Sector and Competitors
1st jan.Capi. (M$)
PHARMADRUG INC.-43.75%12
JOHNSON & JOHNSON4.09%433 701
ROCHE HOLDING AG10.97%321 442
PFIZER, INC.19.23%246 078
NOVO NORDISK A/S50.80%232 556
ELI LILLY AND COMPANY37.20%208 604